Key Practice Fields
Glenn Hughes is a Partner of Russells, a specialised corporate and commercial law firm practising in Sydney and Brisbane.
He specialises in mergers and acquisitions, joint ventures, corporate reconstructions, capital raisings, with a focus on private equity, restructuring and insolvency.
Glenn has acted for ASX-listed entities, Australian based private equity investors, foreign investors, SME’s and high net worth individuals as well as receivers, managers and administrators.
Glenn is very experienced in structuring and negotiating complex mergers, acquisitions, divestments and new ventures. He has a particular focus on the technology, healthcare and financial services industries.
Glenn has been recognised as one of Australia’s leading lawyers in private equity (IFLR 2012, ALB 2009, ALB 2007).
Acted for Biosceptre, a biotech R&D business investigating and exploiting a promising new target for the treatment of cancer, on its re domicile, by way of scheme of arrangement, to the UK.
Legg Mason Inc
Acted for Legg Mason, a US investment management firm, on the securityholder arrangements underpinning its majority buy out of Rare Infrastructure Limited from ASX listed Pacific Current Group Limited (formerly Treasury Group Limited).
Mercurial Insights Holdings Pty Limited
Acted for the shareholders of Mercurial Insights Holdings Pty Limited, a service provider specialising in sales and marketing effectiveness, performance management and cloud based business intelligence, to the Australian subsidiary of NYSE listed IMS Health Holdings Inc, a leading global information and technology services company in the healthcare industry.
Acted for the corporate and individual shareholders of Micreo Limited, a specialised electronic warfare subsystem provider to global defence companies, in respect of the sale of all of the securities in Micreo Limited to NYSE listed company, L 3 Communications Inc.
Prima BioMed Limited
Acted for Prima BioMed Limited, a cancer treatment development company listed on both the ASX and NASDAQ, in respect of its acquisition of Immutep SA, a Paris based chemoimmunotherapy research and licensing business.
SEB Private Equity
Acted for SEB PE Fund II, a leading Nordic based global private equity investor, on the Australian aspects of its global acquisition of Accedo Broadband.
Security and Intelligence Services (India) Limited
Acted for SIS India, one of the largest security services businesses in India and Australia, on the Australian aspects of its proposed Indian IPO.
Sonic Healthcare Limited
Acted for Sonic subsidiary, Sonic HealthPlus Pty Ltd, in respect of its acquisition of the workplace health and travel vaccination businesses of Medibank Private Limited (ASX: MPL).
Acted for Sonic subsidiary, Sonic Clinical Services Pty Ltd, in respect of its acquisition and funding of Apollo Health, a medical centre developer and operator, and subsequent disposal to St John Ambulance.
Acted for Sonic subsidiary, Sonic Clinical Services Pty Ltd, in respect of its acquisition of Allied Medical Group, a major Victorian medical centre operator.
Advised Sir Richard Branson on the Corporations Act implications of proposed changes to his shareholding in Virgin Airlines and the potential establishment of, and funding for, an Australian base for the Virgin Galactic enterprise.
Wolseley Private Equity
Acted for WPE, a leading domestic private equity manager, on the acquisition and ongoing care and maintenance of Byron Group Holdings, a custom design and engineering business that provides services to the aviation and healthcare sectors.
Professional Publications and Committees